Literature DB >> 26177091

Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils.

Wenhua Chu1, Dong Zhou1, Vrinda Gaba2, Jialu Liu2, Shihong Li1, Xin Peng1, Jinbin Xu1, Dhruva Dhavale2, Devika P Bagchi2, André d'Avignon3, Naomi B Shakerdge4, Brian J Bacskai4, Zhude Tu1, Paul T Kotzbauer2, Robert H Mach1,4.   

Abstract

A series of 3-(benzylidine)indolin-2-one derivatives were synthesized and evaluated for their in vitro binding to alpha synuclein (α-syn), beta amyloid (Aβ), and tau fibrils. Compounds with a single double bond in the 3-position had only a modest affinity for α-syn and no selectivity for α-syn versus Aβ or tau fibrils. Homologation to the corresponding diene analogues yielded a mixture of Z,E and E,E isomers; substitution of the indoline nitrogen with an N-benzyl group resulted in increased binding to α-syn and reasonable selectivity for α-syn versus Aβ and tau. Introduction of a para-nitro group into the benzene ring of the diene enabled separation of the Z,E and E,E isomers and led to the identification of the Z,E configuration as the more active regioisomer. The data described here provide key structural information in the design of probes which bind preferentially to α-syn versus Aβ or tau fibrils.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177091      PMCID: PMC4624220          DOI: 10.1021/acs.jmedchem.5b00571

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

1.  Ligand polarizability contributes to tau fibril binding affinity.

Authors:  Jordan R Jensen; Katryna Cisek; Nicolette S Honson; Jeff Kuret
Journal:  Bioorg Med Chem       Date:  2011-07-19       Impact factor: 3.641

2.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

3.  Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.

Authors:  Manuela Ariza; Hartmuth C Kolb; Dieder Moechars; Frederik Rombouts; José Ignacio Andrés
Journal:  J Med Chem       Date:  2015-02-25       Impact factor: 7.446

4.  Synthesis of 18F-labelled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB.

Authors:  K Serdons; T Verduyckt; D Vanderghinste; J Cleynhens; P Borghgraef; P Vermaelen; C Terwinghe; F Van Leuven; K Van Laere; H Kung; G Bormans; A Verbruggen
Journal:  Bioorg Med Chem Lett       Date:  2008-12-24       Impact factor: 2.823

Review 5.  Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

Authors:  Daniel M Skovronsky; Virginia M-Y Lee; John Q Trojanowski
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

6.  Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.

Authors:  L Sun; N Tran; F Tang; H App; P Hirth; G McMahon; C Tang
Journal:  J Med Chem       Date:  1998-07-02       Impact factor: 7.446

7.  The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

Authors:  William E Klunk; Yanming Wang; Guo-feng Huang; Manik L Debnath; Daniel P Holt; Li Shao; Ronald L Hamilton; Milos D Ikonomovic; Steven T DeKosky; Chester A Mathis
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

8.  Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

Authors:  David T Chien; A Katrin Szardenings; Shadfar Bahri; Joseph C Walsh; Fanrong Mu; Chunfang Xia; William R Shankle; Alan J Lerner; Min-Ying Su; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.

Authors:  Chester A Mathis; Yanming Wang; Daniel P Holt; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

10.  Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein.

Authors:  Xiang Zhang; Hongjun Jin; Prashanth K Padakanti; Junfeng Li; Hao Yang; Jinda Fan; Robert H Mach; Paul Kotzbauer; Zhude Tu
Journal:  Appl Sci (Basel)       Date:  2014-03-17       Impact factor: 2.679

View more
  31 in total

1.  Synthesis and characterization of high affinity fluorogenic α-synuclein probes.

Authors:  Zsofia Lengyel-Zhand; John J Ferrie; Bieneke Janssen; Chia-Ju Hsieh; Thomas Graham; Kui-Ying Xu; Conor M Haney; Virginia M-Y Lee; John Q Trojanowski; E James Petersson; Robert H Mach
Journal:  Chem Commun (Camb)       Date:  2020-03-24       Impact factor: 6.222

Review 2.  Small-molecule PET Tracers for Imaging Proteinopathies.

Authors:  Chester A Mathis; Brian J Lopresti; Milos D Ikonomovic; William E Klunk
Journal:  Semin Nucl Med       Date:  2017-07-13       Impact factor: 4.446

3.  A sensitive assay reveals structural requirements for α-synuclein fibril growth.

Authors:  Dhruva D Dhavale; Christina Tsai; Devika P Bagchi; Laura A Engel; Jonathan Sarezky; Paul T Kotzbauer
Journal:  J Biol Chem       Date:  2017-04-03       Impact factor: 5.157

4.  Pharmacophore modeling and 3D-QSAR study for the design of novel α-synuclein aggregation inhibitors.

Authors:  Jixia Yang; Jiajing Hu; Gongzheng Zhang; Li Qin; Hongliang Wen; Yun Tang
Journal:  J Mol Model       Date:  2021-08-25       Impact factor: 1.810

5.  1-Indanone and 1,3-indandione Derivatives as Ligands for Misfolded α-Synuclein Aggregates.

Authors:  Xianwei Sun; Prasad Admane; Zbigniew A Starosolski; Jason L Eriksen; Ananth V Annapragada; Eric A Tanifum
Journal:  ChemMedChem       Date:  2021-11-08       Impact factor: 3.466

Review 6.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

7.  Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregation.

Authors:  Xuyi Yue; Dhruva D Dhavale; Junfeng Li; Zonghua Luo; Jialu Liu; Hao Yang; Robert H Mach; Paul T Kotzbauer; Zhude Tu
Journal:  Bioorg Med Chem Lett       Date:  2018-02-16       Impact factor: 2.823

8.  Resonance assignments of an α-synuclein fibril prepared in Tris buffer at moderate ionic strength.

Authors:  Alexander M Barclay; Dhruva D Dhavale; Joseph M Courtney; Paul T Kotzbauer; Chad M Rienstra
Journal:  Biomol NMR Assign       Date:  2018-02-23       Impact factor: 0.746

9.  [11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates.

Authors:  Laura Kuebler; Sabrina Buss; Andrei Leonov; Sergey Ryazanov; Felix Schmidt; Andreas Maurer; Daniel Weckbecker; Anne M Landau; Thea P Lillethorup; Daniel Bleher; Ran Sing Saw; Bernd J Pichler; Christian Griesinger; Armin Giese; Kristina Herfert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-28       Impact factor: 9.236

Review 10.  New protein deposition tracers in the pipeline.

Authors:  Aleksandar Jovalekic; Norman Koglin; Andre Mueller; Andrew W Stephens
Journal:  EJNMMI Radiopharm Chem       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.